(Q47966144)

7 February 2018

title

Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo (English)

1 reference

7 February 2018

1 reference

6

1 reference

7 February 2018

Jane E Collins

object named as

Jane E Collins

14

0 references

Stuart J Forbes

object named as

Stuart J Forbes

13

0 references

author name string

Jonathan A Fallowfield

1

1 reference

7 February 2018

Annette L Hayden

2

1 reference

7 February 2018

Victoria K Snowdon

3

1 reference

7 February 2018

Rebecca L Aucott

4

1 reference

7 February 2018

Ben M Stutchfield

5

1 reference

7 February 2018

Antonella Pellicoro

7

1 reference

7 February 2018

Timothy T Gordon-Walker

8

1 reference

7 February 2018

Alexander Henke

9

1 reference

7 February 2018

Joerg Schrader

10

1 reference

7 February 2018

Palak J Trivedi

11

1 reference

7 February 2018

Marc Princivalle

12

1 reference

7 February 2018

John P Iredale

15

1 reference

7 February 2018

language of work or name

English

0 references

publication date

3 March 2014

1 reference

7 February 2018

published in

Hepatology

1 reference

7 February 2018

volume

59

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

1492-1504

1 reference

7 February 2018

Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension

cites work

1 reference

7 January 2021

Stellate cells and the "reversible component" of portal hypertension

1 reference

7 January 2021

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

1 reference

7 January 2021

Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension

1 reference

7 January 2021

Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation.

1 reference

7 January 2021

Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

1 reference

7 January 2021

Liver function improvement following increased portal blood flow in cirrhotic rats.

1 reference

7 January 2021

Relaxin's physiological roles and other diverse actions

1 reference

7 January 2021

New insights into the evolution of the relaxin-LGR signaling system

1 reference

7 January 2021

Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation

1 reference

7 January 2021

Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

1 reference

7 January 2021

Elevated circulating plasma endothelin-1 concentrations in cirrhosis

1 reference

7 January 2021

The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus

1 reference

7 January 2021

Relaxin is a potent renal vasodilator in conscious rats

1 reference

7 January 2021

Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats

1 reference

7 January 2021

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

1 reference

7 January 2021

In vivo monitoring of hepatic oxygenation changes in chronically ethanol‐treated rats by functional magnetic resonance imaging

1 reference

7 January 2021

Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells

1 reference

7 January 2021

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

1 reference

7 January 2021

Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response.

1 reference

7 January 2021

Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green

1 reference

7 January 2021

Animal models of portal hypertension

1 reference

7 January 2021

Renal hemodynamics during pregnancy in chronically catheterized, conscious rats

1 reference

7 January 2021

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

1 reference

7 January 2021

The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway

1 reference

7 January 2021

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

1 reference

7 January 2021

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

1 reference

7 January 2021

Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide

1 reference

7 January 2021

Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.

1 reference

7 January 2021

Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.

1 reference

7 January 2021

Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP.

1 reference

7 January 2021

Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26627

1 reference

7 February 2018

PubMed ID

23873655

1 reference

7 February 2018